臓器オンチップ市場レポート：提供、タイプ、用途、最終用途、地域別、2024年～2032年

臓器オンチップの世界市場規模は2023年に6,160万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに5億4,180万米ドルに達し、2024年から2032年の間に26.5％の成長率（CAGR）を示すと予測しています。この市場を牽引しているのは、技術的進歩、共同作業、医学研究におけるより正確で人道的な代替手段を通じた動物実験の削減に対する規制および倫理的重点の高まりによって刺激された、医薬品研究開発の強化における重要な役割です。

臓器オンチップ市場分析：

主要市場促進要因：医薬品とバイオテクノロジーにおける、より正確で倫理的な調査方法の必要性により、臓器オンチップ市場は急速に拡大しています。

主な市場動向：3Dバイオプリンティングやマイクロ流体工学などの技術的進歩が臓器オンチップモデルに革命をもたらし、その精度と応用可能性を高めています。

地理的動向：北米は強固な研究インフラと積極的な規制政策に支えられて市場をリードしているが、欧州とアジア太平洋はバイオテクノロジーへの投資増加により急速に追い上げています。

競合情勢：臓器オンチップ業界の主な市場プレイヤーとしては、Allevi Inc.、Altis Biosystems、AxoSim、BiomimX S.r.l.、Elveflow、Emulate Inc.、InSphero、MIMETAS、Nortis Inc.、TARA Biosystems Inc.、TissUse GmbHなどが挙げられます。

課題と機会：技術的な複雑さと高コストが課題となる一方で、個別化医療へのシフトの進展と多臓器モデルへの拡大が重要な機会となります。

臓器オンチップ市場動向：

医薬品研究開発の強化

臓器オンチップ市場の可能性が大きく広がるのは、医薬品開発・発見を劇的に強化できるからです。これらの技術は、従来の2次元細胞培養や動物モデルと比較して、人間の臓器がどのように反応するかをより正確にシミュレーションできるため、薬剤の試験や開発にかかる時間を短縮するのに役立ちます。したがって、この技術革新は、創薬の期間、コスト、失敗率を減らすために不可欠な、比類のない予測精度を提供します。その結果、製薬会社は臓器オンチップ技術を研究開発プロセスに組み込んでギャップを縮め、個別化医療や精密医療の進歩、治療成功率の向上につなげようとしています。さらに、このシフトは、最終段階で失敗した医薬品のコストを部分的にカバーする、多くの迅速な医薬品承認の見通しを生み出しています。

技術革新と提携

絶え間ない技術の進歩は、臓器オンチップ産業を変革する大きな刺激のひとつです。複数の臓器システムの機能を同時に再現できるチップの製造は、より完全な分析ツールであり、前臨床試験の第一段階をカバーし、臨床試験をより人々に近いものにします。現在行われている発明には、マイクロ流体工学、多次元構造内の細胞の3Dプリンティング、臓器オンチップ・システムのより良い機能性と拡張性を可能にする自動イメージングなどがあります。さらに、バイオテクノロジー企業、研究機関、技術スペシャリストの連携は、学際的な研究のための戦略的環境を形成し、その結果、この分野の迅速な改善をもたらしています。このような協力関係は、技術的な問題を克服し、アプリケーションを向上させるだけでなく、毒物検査、疾患モデリング、精密医療といった様々な分野を促進するために不可欠です。例えば、臓器オンチップ（OOC）技術は、より正確な予測モデルを提供することで、従来のin vitro ADMEおよび毒性試験に革命をもたらし、年間15％の成長率が推定される医薬品開発を強化します。多臓器システムを組み込んだOOCプラットフォームは、薬物動態学的および薬力学的試験を強化し、薬剤分子の時間および用量依存性効果に関する洞察を提供します。臓器オンチップ市場の売上に基づくと、2025年までに2億2,000万米ドルの市場規模に達すると予測されるこれらの先端技術は、正確なフロー制御と迅速なサンプル処理によって従来の2次元培養を凌駕し、有効性試験や毒性評価に不可欠なものとなっています。

規制と倫理の変化

科学研究における動物の使用に関する倫理的問題や規制の強化は、さらに臓器オンチップ産業の成長を刺激しています。世界中の機関や部局が、動物モデルよりも適切なデータを提供するこれらの技術の価値を認識しつつあります。これが、USFDAの臓器オンチップ・プログラムのような試みによって推進されていることです。従って、この移行は、動物に優しい調査技術を求める国民や政府の高まりと一致しています。臓器オンチップ技術は、より高い規制基準を満たすだけでなく、より人間的で科学的に高度な研究技術へのパラダイムシフトを促進することができるため、倫理的にも正当化されます。このような倫理的観点は、研究開発で使用される臓器オンチップデバイスを広く承認する上で、ますます重要な役割を果たすようになってきています。

本レポートで扱う主な質問

• 2023年の世界の臓器オンチップ市場の市場規模は？
• 2024-2032年の世界の臓器オンチップ市場の予想成長率は？
• 世界の臓器オンチップ市場を牽引する主な要因は？
• 世界の臓器オンチップ市場に対するCOVID-19の影響は？
• 世界の臓器オンチップ市場のタイプ別内訳は？
• 世界の臓器オンチップ市場の用途別内訳は？
• 世界の臓器オンチップ市場の主要地域は？
• 世界の臓器オンチップ市場の主要プレーヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の臓器オンチップ市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：提供別

• 製品
  • 市場動向
  • 市場予測
• サービス
  • 市場動向
  • 市場予測

第7章 市場内訳：タイプ別

• 肝臓
  • 市場動向
  • 市場予測
• 心臓
  • 市場動向
  • 市場予測
• 肺
  • 市場動向
  • 市場予測
• 腎臓
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：用途別

• 生理学的モデルの開発
  • 市場動向
  • 市場予測
• 創薬
  • 市場動向
  • 市場予測
• 毒性学調査
  • 市場動向
  • 市場予測

第9章 市場内訳：最終用途別

• 製薬・バイオテクノロジー企業
  • 市場動向
  • 市場予測
• 学術研究機関
  • 市場動向
  • 市場予測
• 化粧品業界
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第11章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Allevi Inc.
  • Altis Biosystems
  • AxoSim
  • BiomimX S.r.l.
  • Elveflow
  • Emulate Inc.
  • InSphero
  • MIMETAS
  • Nortis Inc.
  • TARA Biosystems Inc.
  • TissUse GmbH

List of Figures

• Figure 1: Global: Organ-on-chip Market: Major Drivers and Challenges
• Figure 2: Global: Organ-on-chip Market: Sales Value (in Million US$), 2018-2023
• Figure 3: Global: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 4: Global: Organ-on-chip Market: Breakup by Offering (in %), 2023
• Figure 5: Global: Organ-on-chip Market: Breakup by Type (in %), 2023
• Figure 6: Global: Organ-on-chip Market: Breakup by Application (in %), 2023
• Figure 7: Global: Organ-on-chip Market: Breakup by End Use (in %), 2023
• Figure 8: Global: Organ-on-chip Market: Breakup by Region (in %), 2023
• Figure 9: Global: Organ-on-chip (Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Organ-on-chip (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Organ-on-chip (Services) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Organ-on-chip (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Organ-on-chip (Liver) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Organ-on-chip (Liver) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Organ-on-chip (Heart) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Organ-on-chip (Heart) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Organ-on-chip (Lung) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Organ-on-chip (Lung) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Organ-on-chip (Kidney) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Global: Organ-on-chip (Kidney) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Global: Organ-on-chip (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Organ-on-chip (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Global: Organ-on-chip (Physiological Model Development) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Global: Organ-on-chip (Physiological Model Development) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Global: Organ-on-chip (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Global: Organ-on-chip (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Global: Organ-on-chip (Toxicology Research) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Global: Organ-on-chip (Toxicology Research) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Global: Organ-on-chip (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Global: Organ-on-chip (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: Global: Organ-on-chip (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: Global: Organ-on-chip (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Global: Organ-on-chip (Cosmetics Industry) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Global: Organ-on-chip (Cosmetics Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: Global: Organ-on-chip (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: Global: Organ-on-chip (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: North America: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: North America: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: United States: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: United States: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Canada: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Canada: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: Asia-Pacific: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: Asia-Pacific: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: China: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: China: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: Japan: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: Japan: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: India: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: India: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: South Korea: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: South Korea: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: Australia: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: Australia: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: Indonesia: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: Indonesia: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: Others: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: Others: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: Europe: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: Europe: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: Germany: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: Germany: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 63: France: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 64: France: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 65: United Kingdom: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 66: United Kingdom: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 67: Italy: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 68: Italy: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 69: Spain: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 70: Spain: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 71: Russia: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 72: Russia: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 73: Others: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 74: Others: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 75: Latin America: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 76: Latin America: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 77: Brazil: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 78: Brazil: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 79: Mexico: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 80: Mexico: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 81: Others: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 82: Others: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 83: Middle East and Africa: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
• Figure 84: Middle East and Africa: Organ-on-chip Market: Breakup by Country (in %), 2023
• Figure 85: Middle East and Africa: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 86: Global: Organ-on-chip Industry: SWOT Analysis
• Figure 87: Global: Organ-on-chip Industry: Value Chain Analysis
• Figure 88: Global: Organ-on-chip Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Organ-on-chip Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Organ-on-chip Market Forecast: Breakup by Offering (in Million US$), 2024-2032
• Table 3: Global: Organ-on-chip Market Forecast: Breakup by Type (in Million US$), 2024-2032
• Table 4: Global: Organ-on-chip Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 5: Global: Organ-on-chip Market Forecast: Breakup by End Use (in Million US$), 2024-2032
• Table 6: Global: Organ-on-chip Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 7: Global: Organ-on-chip Market: Competitive Structure
• Table 8: Global: Organ-on-chip Market: Key Players

The global organ-on-chip market size reached US$ 61.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 541.8 Million by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032. The market is driven by its critical role in enhancing pharmaceutical R&D, stimulated by technological advancements, collaborative efforts, and increasing regulatory and ethical emphasis on reducing animal testing through more accurate and humane alternatives in medical research.

Organ-on-chip Market Analysis:

Major Market Drivers: The organ-on-chip market is expanding rapidly, driven by the need for more accurate and ethical research methods in pharmaceuticals and biotechnology.

Key Market Trends: Technological advancements such as 3D bioprinting and microfluidics are revolutionizing organ-on-chip models, increasing their accuracy and applicability.

Geographical Trends: North America leads the market, supported by robust research infrastructure and proactive regulatory policies; however, Europe and Asia-Pacific are quickly catching up due to rising investments in biotech.

Competitive Landscape: Some of the major market players in the organ-on-chip industry include Allevi Inc., Altis Biosystems, AxoSim, BiomimX S.r.l., Elveflow, Emulate Inc., InSphero, MIMETAS, Nortis Inc., TARA Biosystems Inc., TissUse GmbH., etc. among many others.

Challenges and Opportunities: While technological complexities and high costs pose challenges, the growing shift towards personalized medicine and the expansion into multi-organ models present significant organ-on-chip market opportunities.

Organ-on-chip Market Trends:

Pharmaceutical Research and Development Enhancement

The organ-on-chip market potential is greatly increased because it can dramatically enhance drug development and discovery. These techniques provide a more precise simulation of how human organs respond compared to conventional 2D cell cultures, and animal models and hence they help to reduce the time taken in drug testing and development. This innovation, thus, offers unparalleled prediction accuracy, essential for decreasing the duration, cost, and failure rates during drug discovery. As a result, pharmaceutical organizations are starting to integrate organ-on-chip technologies into their R&D processes to narrow the gap, leading to the advancement of personalized and precise medicine and higher therapeutic success rates. Besides, this shift produces the prospect of many quick drug approvals which partly cover the cost of those that failed in the final stage.

Technological Innovations and Collaborations

Continuous technological advancements are one of the major stimuli that are transforming the organ-on-chip industry. The manufacturing of chips capable of replicating several organ systems' functionalities at the same time is a more complete analysis tool, covering the first stage of preclinical testing and bringing clinical trials closer to the population. The inventions being made include incorporating microfluidics, 3D printing of cells within multi-dimensional structures, and automated imaging which allows for better functionality and scalability of organ-on-chip systems. Furthermore, associations between biotech firms, research institutions, and technology specialists have formed a strategic environment for cross-disciplinary studies that, in turn, results in fast improvements in this field. These collaborations are vital to overcoming technical issues and improving applications, as well as promoting various sectors like toxic things testing, disease modeling, and precision medicine. For instance, Organ-on-chip (OOC) technology revolutionizes traditional in vitro ADME and toxicity tests by offering a more accurate predictive model, enhancing drug development with an estimated growth rate of 15% annually. Incorporating multi-organ systems, OOC platforms enhance pharmacokinetic and pharmacodynamic studies, providing insights into the time and dose-dependent effects of drug molecules. Based on organ-on chip market revenue, these advanced technology, projected to reach a market size of $220 million by 2025, outperforms conventional 2D cultures with its precise flow control and rapid sample processing, making it essential for efficacy studies and toxicity evaluations.

Regulatory and Ethical Shifts

Ethical issues and stricter regulations concerning the application of animals in scientific research are additionally stimulating the growth of the organ-on-chip industry. Agencies and departments all around the world are coming to recognize the value of these technologies in providing more relevant data than animal models. This is what is being promoted by endeavors such as the USFDA's Organ-on-Chip program. Therefore, this transition is consistent with the growing public and governmental push for animal-friendly investigation techniques. Organ-on-chip technologies, not only qualifying for higher regulatory standards, are also ethically warranted, since they can promote a paradigm shift towards more human and scientifically advanced research techniques. This ethical standpoint is getting an increasing role in wider approval for organ-on-chip devices to be used in research and development.

Organ-on-chip Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on offering, type, application, and end use.

Breakup by Offering:

Products

Services

The report has provided a detailed breakup and analysis of the market based on the offering. This includes products and services.

Breakup by Type:

Liver

Heart

Lung

Kidney

Others

Lung holds the largest share of the industry

A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes the liver, heart, lung, kidney, and others. According to the report, lung accounted for the largest market share.

According to the organ-on-chip market trend, the lung-on-chip is the most expanded due to its high application in respiratory studies and drug discovery. This technology is suitable for modeling the complex structure and function of the human lung to provide a dynamic platform for respiratory diseases, drug response evaluation, and inhaled substances toxicity assessment. Its role in the process of speeding up the development of personalized therapies for different lung diseases, such as asthma and chronic obstructive pulmonary disorder (COPD), is truly emphasized. Lung-on-chip model leads to a more reliable and ethical replacement of animal testing, hence the assurance of drug efficacy and safety to the authorities, which is a prerequisite for successful market entry. This shifts drug discovery and biotechnology to the leadership role in this area, continuing and increasing the organ-on-chip market share.

Breakup by Application:

Physiological Model Development

Drug Discovery

Toxicology Research

Drug discovery represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes physiological model development, drug discovery, and toxicology research. According to the report, drug discovery represented the largest segment.

As per the organ-on-chip market overview, drug discovery is the largest segment for all phases of drug development. This is because the segment has such a key transforming way of developing the processes of pharmaceutical products. Organ-on-chip systems can mimic human organs' responses under various conditions in a way that otherwise would be impossible, allowing scientists to do early screenings for a prospective drug. This ability of the computer successfully enables us to estimate how those drugs will be affected by the human tissues, which in turn creates a step in the right direction of the efficacy and safety test process. It therefore follows that the drug discovery time frame is greatly shortened, and the clinical trial costs and risk become lower. The broadening utilization of these technologies by a pharmaceutical company indicates a great opportunity in this area to make drug hunting faster but not only, less costly and in line with better regulatory requirements for safety and effectiveness.

Breakup by End Use:

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Cosmetics Industry

Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the end use have also been provided in the report. This includes pharmaceutical and biotechnology companies, academic and research institutes, cosmetics industry, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.

The pharmaceutical and biotechnology companies account for the largest market share. This superiority is mainly caused by the increased usage of micro-organ models in the drug discovery and development phases of these industries. The organ-on-chip companies use technology to copy human body functions and its responses to a higher level than conventional methods which use animal experimenting and 2D cell cultures. Improved capacities to match human organ functions and interact in a laboratory setting provide better detection of drug efficacy and toxicity at an early stage of development. It not only improves the prospects of success in the clinical trials but also decreases the time and cost involved in the process of commercialization of a new drug. Being that pharmaceutical and biotechnology company are constantly in search of inventive ways that will accelerate the research and development process, the utilization of organ-on-chip technologies is anticipated to keep increasing, therefore making this segment the largest one in the market and creating a positive organ-on-chip market outlook.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest organ-on-chip market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for organ-on-chip.

According to the organ-on-chip market report, the largest segment here is North America. This superiority comes from a strong research infrastructure, good funding of the biotechnology and pharmaceutical industry, and the exemplary support given to innovative healthcare solutions by the government and the private sector North American confident leadership in the market is further fortified by the existence of leading universities and research institutions that always drive the frontiers of the medical fieldwork with the Increasing organ-on-chip demand in technologies. Other than that, the area fosters an already existing regulatory framework that provides high adoption opportunities of cutting-edge tools for drug development and personalized medicine which include organ-on-chip. The dominance of these economic entities is what pushes other players to innovate the development and deployment of such technologies contribute to the regional prominence in the global market. This active and advanced veterinary system provides organ-on-chip market growth models which makes these models in use in medical research and pharmaceutical testing.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the organ-on-chip industry include:

Allevi Inc.

Altis Biosystems

AxoSim

BiomimX S.r.l.

Elveflow

Emulate Inc.

InSphero

MIMETAS

Nortis Inc.

TARA Biosystems Inc.

TissUse GmbH

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Major players in the organ-on-chip industry keep improving and broadening their technological arsenals by different means, including research and development, cooperation, and mergers and acquisitions. According to organ-on-chip recent developments businesses aim to develop more specific and versatile organ-on-chip models capable of simulating human physiology more precisely for drug testing and disease modeling. The pragmatic cooperation is responsible for the quick product commercialization of new technologies in addition to broadening the microfluidic systems' application scope in personalized medicine, safety pharmacology, and complex biological research, which consequently fortifies their market positions. According to the organ-on-chip market forecast, strategic collaborations with pharmaceutical companies, academic institutions, and technology providers are creating a positive outlook for the market.

Organ-on-chip Market News:

On March 7, 2023, Allevi, a pioneer in 3D bioprinting, adopted this transformative technology for its ability to accurately mimic human biological systems in animal-free research. Its expanding applications in drug discovery, regenerative and translational medicine, and preclinical research highlight the significant potential of this platform.

On January 23, 2024, CN Bio and Altis Biosystems partnered to create an advanced human Gut/Liver in vitro model for improved ADME studies, leveraging their organ-specific expertise for more accurate predictions. This next-generation Organ-on-a-Chip solution is available early through CN Bio's Contract Research Services.

On October 24, 2023, AxoSim, Inc., a leader in biomimetic human drug discovery platforms for neurological diseases, has completed its acquisition of microBrain(TM) assets from Vyant Bio's StemoniX subsidiary. This move enhances AxoSim's capabilities in advancing neurological research.

Key Questions Answered in This Report

• 1. What was the size of the global organ-on-chip market in 2023?
• 2. What is the expected growth rate of the global organ-on-chip market during 2024-2032?
• 3. What are the key factors driving the global organ-on-chip market?
• 4. What has been the impact of COVID-19 on the global organ-on-chip market?
• 5. What is the breakup of the global organ-on-chip market based on the type?
• 6. What is the breakup of the global organ-on-chip market based on the application?
• 7. What is the breakup of the global organ-on-chip market based on the end use?
• 8. What are the key regions in the global organ-on-chip market?
• 9. Who are the key players/companies in the global organ-on-chip market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Organ-on-chip Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Offering

• 6.1 Products
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Type

• 7.1 Liver
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Heart
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Lung
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Kidney
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Application

• 8.1 Physiological Model Development
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Drug Discovery
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Toxicology Research
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End Use

• 9.1 Pharmaceutical and Biotechnology Companies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Academic and Research Institutes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Cosmetics Industry
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Allevi Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Altis Biosystems
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 AxoSim
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 BiomimX S.r.l.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Elveflow
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Emulate Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 InSphero
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 MIMETAS
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Nortis Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 TARA Biosystems Inc.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 TissUse GmbH
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio